Frontlight ResearchEarly access
Retinitis pigmentosa trials in Belgium
3 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in BelgiumA Phase 1/2/3 Study of ATSN-201 Gene Therapy in Subjects with RS1-Associated X linked Retinoschisis
- Where
- Ghent University Hospital
- People
- 36 worldwide
- Run by
- Atsena Therapeutics Inc.
See details and how to joinNCT05878860 · EU 2026-525886-38-00 - No phaseTaking peopleNatural History Study of Advanced RCD
- Where
- Ghent
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- SparingVision
See details and how to joinNCT07854899 - Phase 1/2Taking peopleOpen-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy
- Where
- Ghent
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- SparingVision
See details and how to joinNCT07807111 · EU 2025-520665-47-00